These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19567998)

  • 21. Expression of natriuretic peptide receptor mRNA and functional response to atrial natriuretic peptide and C-type natriuretic peptide in rainbow trout (Oncorhynchus mykiss) head kidney leucocytes.
    Powell MD; McWilliam H; McLeod J; Nankervis S; Butler R; Toop T
    Fish Shellfish Immunol; 2008 Apr; 24(4):373-8. PubMed ID: 18282766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-natriuretic peptide: an important regulator of cartilage.
    Pejchalova K; Krejci P; Wilcox WR
    Mol Genet Metab; 2007 Nov; 92(3):210-5. PubMed ID: 17681481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification.
    Tsuji T; Kondo E; Yasoda A; Inamoto M; Kiyosu C; Nakao K; Kunieda T
    Biochem Biophys Res Commun; 2008 Nov; 376(1):186-90. PubMed ID: 18775416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Kishimoto I; Yamahara K; Osaki T; Minamino N; Horio T; Sawai K; Kawano Y; Miyazato M; Sata M; Kohno M; Nakao K; Kangawa K
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1516-21. PubMed ID: 19628785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
    Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
    Dickey DM; Otto NM; Potter LR
    J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natriuretic peptides--their receptors and role in cardiovascular system].
    Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2008; 54(1):35-42. PubMed ID: 18610580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-type natriuretic peptide and overgrowth.
    Bocciardi R; Ravazzolo R
    Endocr Dev; 2009; 14():61-6. PubMed ID: 19293575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
    Bartels CF; Bükülmez H; Padayatti P; Rhee DK; van Ravenswaaij-Arts C; Pauli RM; Mundlos S; Chitayat D; Shih LY; Al-Gazali LI; Kant S; Cole T; Morton J; Cormier-Daire V; Faivre L; Lees M; Kirk J; Mortier GR; Leroy J; Zabel B; Kim CA; Crow Y; Braverman NE; van den Akker F; Warman ML
    Am J Hum Genet; 2004 Jul; 75(1):27-34. PubMed ID: 15146390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
    Bocciardi R; Giorda R; Buttgereit J; Gimelli S; Divizia MT; Beri S; Garofalo S; Tavella S; Lerone M; Zuffardi O; Bader M; Ravazzolo R; Gimelli G
    Hum Mutat; 2007 Jul; 28(7):724-31. PubMed ID: 17373680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families.
    Irfanullah ; Umair M; Khan S; Ahmad W
    Ann Hum Genet; 2015 Jul; 79(4):238-44. PubMed ID: 25959430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of C-type natriuretic peptide on craniofacial skeletogenesis.
    Nakao K; Okubo Y; Yasoda A; Koyama N; Osawa K; Isobe Y; Kondo E; Fujii T; Miura M; Nakao K; Bessho K
    J Dent Res; 2013 Jan; 92(1):58-64. PubMed ID: 23114031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-type natriuretic peptide enhances amylase release through NPR-C receptors in the exocrine pancreas.
    Sabbatini ME; Rodríguez M; di Carlo MB; Davio CA; Vatta MS; Bianciotti LG
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G987-94. PubMed ID: 17702953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function.
    Peake NJ; Hobbs AJ; Pingguan-Murphy B; Salter DM; Berenbaum F; Chowdhury TT
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1800-7. PubMed ID: 25086404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases.
    Kuhn M
    Handb Exp Pharmacol; 2009; (191):47-69. PubMed ID: 19089325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
    Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
    Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system.
    Sabbatini ME
    Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.
    Olney RC; Prickett TC; Espiner EA; Mackenzie WG; Duker AL; Ditro C; Zabel B; Hasegawa T; Kitoh H; Aylsworth AS; Bober MB
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E355-9. PubMed ID: 25387261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Natriuretic peptides as novel growth factor of growth plate cartilage].
    Tanaka K
    Clin Calcium; 2002 Mar; 12(3):352-5. PubMed ID: 15775313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-type natriuretic peptide in reproduction, pregnancy and fetal development.
    Walther T; Stepan H
    J Endocrinol; 2004 Jan; 180(1):17-22. PubMed ID: 14709140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.